A paper published this month estimated that each year in the US about $28.2 billion, or half of the total spending on preclinical research, is used for preclinical studies that are not reproducible. “[T]he existence and propagation of one or more errors, flaws, inadequacies or omissions . . . that prevent replication of results” were […]
The annual JP Morgan Healthcare conference held in early January is a major investor conference for health care companies, including instrument and lab-product companies. Several such companies presented business and strategy updates at the conference, highlighting their successes of the past year and plans for 2015. The information in this article is based on online […]
Company Announcements Bruker announced on its third quarter 2014 conference call that its divestiture of certain GC and GC/MS assets (see IBO 10/15/14) and its ICP-MS (see IBO 8/15/14) business generated approximately $28 million in proceeds. As part of the CAM restructuring, Bruker is relocating GC triple-quadrupole MS manufacturing from Fremont, California, to Bremen, Germany, […]
As is usual for our annual forecast issue, IBO selects a firm from our industry as “company of the year.” In designating the company of the year, IBO recognizes an analytical- and life science–instrument maker that has accomplished technical, operational and financial achievements. Such achievements are a function of strong financial performance, market leadership, innovative […]
Merck KGaA and Sigma-Aldrich Consolidation continued in the lab-products market, as less than a year after Thermo Fisher Scientific’s purchase of Life Technologies (see IBO 2/15/14), Merck KGaA announced a $17 billion deal to buy Sigma-Aldrich (see IBO 9/30/14). The deal highlights the importance of scale and diversification and transforms Merck/EMD Millipore into a major […]
A More Focused Approach As economic headwinds in China, industrial and selected government markets continued in 2014, several analytical-instrument and lab-product companies took steps to focus on a narrower set of businesses and product lines, in some cases, divesting assets and, in other cases, consolidating their positions. Among the year’s most prominent product-line exits were […]
St. Louis, MO 10/3/14—Sigma-Aldrich has agreed to acquire Cell Marque for an undisclosed amount. Cell Marque designs, develops and manufactures antibody reagents and kits for immunohistochemistry. “We expect that Cell Marque’s strong in vitro diagnostic (IVD) antibody product lines and solid relationships with pathologists and companies that provide automated staining instrumentation will broaden the diagnostic-health […]
develop companion diagnostics. Thermo Fisher Scientific on September 25 announced a partnership with GlaxoSmithKline and Pfizer to develop an NGS oncology test for solid tumors. The test will be used as a companion diagnostic for several drug programs after premarket approval from the FDA and other regulatory agencies. The test will apply to CNVs, gene […]
Company Announcements For the fiscal first quarter ending June 30, Hitachi High-Technologies Science and Medical Systems (SMS) sales climbed 33% to ¥38.8 billion ($380.1 million = ¥102.09 = $1) to account for 25% of company revenues (see IBO 7/31/14). Medical product sales jumped 53%, and sales of Biotechnology and Other products grew 16% to account […]
PerkinElmer has launched the AlphaPlex reagent technology for multiplex immunoassay analysis. AlphaPlex is based on the company’s Alpha (amplified luminescence proximity homogenous assays) technology, a homogeneous, bead-based, no-wash assay platform. Alpha Technology offerings also include the AlphaLISA and AlphaScreen reagents. Based on the transfer of energy between Donor and Acceptor beads, AlphaPlex can generate multiple […]
Pay Invoice
Latest Blogs
-
Lab Instrument Sales in China Collapse
March 29, 2024 1:15 pm
-
Pittcon 2024 Comes to San Diego
February 14, 2024 1:10 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
